162 related articles for article (PubMed ID: 37609771)
1. Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
Kervarrec T; Pissaloux D; Tirode F; de la Fouchardière A; Sohier P; Frouin E; Hamard A; Houben R; Schrama D; Barlier A; Cribier B; Battistella M; Macagno N
Histopathology; 2024 Jan; 84(2):266-278. PubMed ID: 37609771
[TBL] [Abstract][Full Text] [Related]
2. Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.
Kervarrec T; Frouin E; Collin C; Tallet A; Tallegas M; Pissaloux D; Tirode F; Guyétant S; Samimi M; Gaboriaud P; Touzé A; Schrama D; Houben R; Tabareau-Delalande F; Neuhart A; de la Fouchardière A; Osio A; Cavelier-Balloy B; Laurent-Roussel S; Sohier P; Cyprien T; Balme B; Belzung F; Jullie ML; Cribier B; Battistella M; Macagno N
Histopathology; 2023 May; 82(6):885-898. PubMed ID: 36720791
[TBL] [Abstract][Full Text] [Related]
3. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
[TBL] [Abstract][Full Text] [Related]
4. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
[TBL] [Abstract][Full Text] [Related]
5. Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.
Li P; Busam KJ
J Cutan Pathol; 2024 Mar; 51(3):226-229. PubMed ID: 38088454
[TBL] [Abstract][Full Text] [Related]
6. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
[TBL] [Abstract][Full Text] [Related]
7. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility.
Parra O; Kerr DA; Bridge JA; Loehrer AP; Linos K
J Cutan Pathol; 2021 Jan; 48(1):95-101. PubMed ID: 32757412
[TBL] [Abstract][Full Text] [Related]
8. Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation.
Kervarrec T; Pissaloux D; Paindavoine S; Tirode F; Osio A; Mourah S; Jouenne F; Sohier P; Calonje E; Pekar A; Luna EVE; Goto K; Delalande F; Frouin E; Macagno N; Drouot F; Faisan M; Cribier B; Battistella M; de la Fouchardière A
Histopathology; 2023 Aug; 83(2):310-319. PubMed ID: 37199682
[TBL] [Abstract][Full Text] [Related]
9. Concomitant poroma and porocarcinoma.
Abarzúa Á; Álvarez-Véliz S; Moll-Manzur C
An Bras Dermatol; 2017; 92(4):550-552. PubMed ID: 28954110
[TBL] [Abstract][Full Text] [Related]
10. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
Russell-Goldman E; Hornick JL; Hanna J
J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
[TBL] [Abstract][Full Text] [Related]
11. Porocarcinoma with YAP1-NUTM1 fusion presenting as a NUT immunohistochemistry-positive lymph node metastasis.
Christensen DJ; Tuluc M
J Cutan Pathol; 2023 May; 50(5):410-414. PubMed ID: 36794976
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
[TBL] [Abstract][Full Text] [Related]
13. Eccrine poroma and porocarcinoma on the same unusual location: report on two cases.
Ma H; Liao M; Qiu S; Lu R; Lu C
An Bras Dermatol; 2015; 90(3 Suppl 1):69-72. PubMed ID: 26312678
[TBL] [Abstract][Full Text] [Related]
14. YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor.
Agaimy A; Stoehr R; Tögel L; Hartmann A; Cramer T
Head Neck Pathol; 2021 Mar; 15(1):361-367. PubMed ID: 32504288
[TBL] [Abstract][Full Text] [Related]
15. [Eccrine poroma and porocarcinoma].
Arbona E; Balme B
Ann Dermatol Venereol; 2010 Oct; 137(10):660-2. PubMed ID: 20932451
[No Abstract] [Full Text] [Related]
16. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.
Bosic M; Kirchner M; Brasanac D; Leichsenring J; Lier A; Volckmar AL; Oliveira C; Buchhalter I; Stögbauer F; Zivkovic-Perisic S; Goeppert B; Schirmacher P; Penzel R; Endris V; Stenzinger A
Pathology; 2018 Apr; 50(3):327-332. PubMed ID: 29269125
[TBL] [Abstract][Full Text] [Related]
17. Poroma: a review of eccrine, apocrine, and malignant forms.
Sawaya JL; Khachemoune A
Int J Dermatol; 2014 Sep; 53(9):1053-61. PubMed ID: 24697501
[TBL] [Abstract][Full Text] [Related]
18. [Tumors with poroid features: a clinicopathologic analysis of 45 cases].
Yao H; Liu J; Su J; Zheng Jie ; Liao S
Zhonghua Bing Li Xue Za Zhi; 2015 Mar; 44(3):179-83. PubMed ID: 26268752
[TBL] [Abstract][Full Text] [Related]
19. Eccrine poroma and eccrine porocarcinoma in linear epidermal nevus.
Jeon J; Kim JH; Baek YS; Kim A; Seo SH; Oh CH
Am J Dermatopathol; 2014 May; 36(5):430-2. PubMed ID: 24803063
[No Abstract] [Full Text] [Related]
20. An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature.
Hartsough EM; Moran J; Devins K; Wszolek M; Cornejo KM
Am J Dermatopathol; 2023 Jan; 45(1):51-55. PubMed ID: 36484607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]